Acurx Pharmaceuticals

(NASDAQ) ACXP

Current Price$1.44

Market Cap$6.32M

Since IPO (2021)-99%

5 Year-99%

1 Year-88%

1 Month-25%

Acurx Pharmaceuticals Financials at a Glance

Market Cap

$6.32M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.50M

EPS (TTM)

-$4.40

P/E Ratio

-0.33

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.44

Volume

Open

$1.45

Price

$1.44

Volume

Open

$1.45

Previous Close

$1.47

Daily Range

$1.42 - $1.49

52-Week Range

$1.33 - $11.73

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.44

Volume

Open

$1.45

Previous Close

$1.47

Daily Range

$1.42 - $1.49

52-Week Range

$1.33 - $11.73

Estimated Earnings Date

Aug 10, 2026

ACXP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acurx Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David P. Luci, CPA

Website

www.acurxpharma.com

Headquarters

Staten Island, NY 10305, US

ACXP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-153.93%

Return on Capital

-153.59%

Return on Assets

-78.60%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.32M

Shares Outstanding

4.30M

Volume

Avg. Volume

134.41K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$7.63M

EBITDA

-$7.50M

Operating Cash Flow

-$6.14M

Capital Expenditure

$3.00

Free Cash Flow

-$6.14M

Cash & ST Invst.

$9.25M

Total Debt

$0.00

Acurx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.32M

N/A

Market Cap/Employee

$1.58M

N/A

Employees

N/A

Net Income

-$1.68M

+21.8%

EBITDA

-$1.68M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$9.25M

+99.3%

Total Debt

$0.00

N/A

Accounts Receivable

$56.31K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-78.60%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

-$1.41M

+31.4%

Operating Cash Flow

-$1.41M

+31.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.06+6.00%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.81-2.38%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.00+1.52%

ADILAdial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.$2.48-2.75%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$1.11+2.78%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.74+2.27%

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.94+3.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.86+0.26%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.45+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.30-0.01%

NOKNokia

NOKNokia$13.81+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

SMCISuper Micro Computer

SMCISuper Micro Computer$32.45-0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.31+0.00%

Questions About ACXP

What is the current price of Acurx Pharmaceuticals?

Acurx Pharmaceuticals is trading at $1.47 per share.

What is the 52-week range for Acurx Pharmaceuticals?

Over the past 52 weeks, Acurx Pharmaceuticals has traded between $1.33 and $11.73.

How much debt does Acurx Pharmaceuticals have?

As of the most recent reporting period, Acurx Pharmaceuticals reported total debt of $0.00.

How much cash does Acurx Pharmaceuticals have on hand?

Acurx Pharmaceuticals reported $9.25M in cash and cash equivalents in its most recent financial results.

What is Acurx Pharmaceuticals’s dividend yield?

Acurx Pharmaceuticals does not currently have a dividend yield.

Acurx Pharmaceuticals

Acurx Pharmaceuticals Financials at a Glance

ACXP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acurx Pharmaceuticals

ACXP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acurx Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACXP

What is the current price of Acurx Pharmaceuticals?

What is the 52-week range for Acurx Pharmaceuticals?

How much debt does Acurx Pharmaceuticals have?

How much cash does Acurx Pharmaceuticals have on hand?

What is Acurx Pharmaceuticals’s dividend yield?

Premium Investing Services